新型出生前診断(NIPT)の世界市場2016-2020

◆英語タイトル:Global Non-Invasive Prenatal Testing Market 2016-2020
◆商品コード:IRTNTR9873
◆発行会社(調査会社):Technavio
◆発行日:2016年8月30日
◆ページ数:70
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:バイオ技術
◆販売価格オプション(消費税別)
Single User(1名利用)USD2,500 ⇒換算¥277,500見積依頼/購入/質問フォーム
Five User(~5名利用)USD3,000 ⇒換算¥333,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD4,000 ⇒換算¥444,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。Technavio社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、新型出生前診断(NIPT)の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、新型出生前診断(NIPT)の世界市場規模及び予測、需要先別分析、地域別分析/市場規模、市場の成長要因、市場の課題、市場動向、競争状況などの情報をお届けいたします。
【レポートの概要】

About NIPT
NIPT is an advanced technology that helps detect fatal chromosomal aneuploidies by analyzing the fetus’ cell-free DNA. It also helps diagnose the risks for genetic disorders such as Down, Turner, Klinefelter, and XYY syndromes, which are common sex chromosomal aneuploidies associated with reproductive loss, infertility, and language development delays. Since its introduction into clinical practice in Hong Kong in 2011, NIPT has rapidly spread across the world.

Technavio’s analysts forecast the global non-invasive prenatal testing (NIPT) market to grow at a CAGR of 17.44% during the period 2016-2020.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global non-invasive prenatal testing (NIPT) market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of testing products.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Non-Invasive Prenatal Testing (NIPT) Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• BGI Genomics
• Illumina
• LifeCodexx
• Natera
• Sequenom

[Other prominent vendors]
• Ariosa Diagnostics
• Berry Genomics
• CombiMatrix
• F. Hoffmann-La Roche
• Genpharm Services
• Laboratory Corporation of America Holdings
• LifeLabs Genetics
• Quest Diagnostics
• Safembryo
• Sengenics

[Market driver]
• Incidence of fetal chromosomal disorders in newborns
• For a full, detailed list, view our report

[Market challenge]
• Limited consumer options and lack of effective product differentiation
• For a full, detailed list, view our report

[Market trend]
• Increase in partnerships and collaborations
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

※You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【レポートの目次】

PART 01: Executive summary
• Highlights

PART 02: Scope of the report
• Market overview
• Top-vendor offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights

PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 06: Market segmentation by testing product
• Global NIPT market for MaterniT21 Plus test
• Global NIPT market for NIFTY test
• Global NIPT market for Harmony test
• Global NIPT market for Bambni test
• Global NIPT market for Verifi test
• Global NIPT market for Panorama test
• Global NIPT market for PrenaTest

PART 07: Market segmentation by end-user
• Hospitals
• Diagnostic clinical laboratories
• Research laboratories and academia

PART 08: Geographical segmentation
• NIPT market in Americas
• NIPT market in EMEA
• NIPT market in APAC

PART 09: Market drivers
• Child-bearing at advanced maternal age
• Incidence of fetal chromosomal disorders in newborns
• Advantages of NIPTs

PART 10: Impact of drivers

PART 11: Market challenges
• Pregnancy termination due to disability
• Limitations of prenatal cell-free DNA screening
• Limited consumer options and lack of effective product differentiation

PART 12: Impact of drivers and challenges

PART 13: Market trends
• Increased volumes of prenatal care counselling in hospitals
• Bioinformatics tools combined with DNA sequencing for NIPTs
• Increase in partnerships and collaborations

PART 14: Vendor landscape
• Competitive scenario

PART 15: Major vendors
• BGI Genomics
• Illumina
• LifeCodexx
• Natera
• Sequenom
• Other prominent vendors

PART 16: Appendix
• List of abbreviations

PART 17: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Global NIPT market ($ millions)
Exhibit 03: Five forces analysis
Exhibit 04: Global NIPT market segmentation by testing product 2015
Exhibit 05: Global NIPT market segmentation by testing product 2020
Exhibit 06: Global NIPT market for Maternit21 Plus test: Metric analysis 2016-2020
Exhibit 07: Global NIPT market for Maternit21 Plus test 2015-2020 ($ millions)
Exhibit 08: Global NIPT market for NIFTY test: Metric analysis 2016-2020
Exhibit 09: Global NIPT market for NIFTY test 2015-2020 ($ millions)
Exhibit 10: Global NIPT market for Harmony test: Metric analysis 2016-2020
Exhibit 11: Global NIPT market for Harmony test 2015-2020 ($ millions)
Exhibit 12: Global NIPT market for Bambni test: Metric analysis 2016-2020
Exhibit 13: Global NIPT market for Bambni test 2015-2020 ($ millions)
Exhibit 14: Sensitivity and specificity of Verifi test
Exhibit 15: Global NIPT market for Verifi test: Metric analysis 2016-2020
Exhibit 16: Global NIPT market for Verifi test 2015-2020 ($ millions)
Exhibit 17: Global NIPT market for Panorama test: Metric analysis 2016-2020
Exhibit 18: Global NIPT market for Panorama test 2015-2020 ($ millions)
Exhibit 19: Detection rate of Panorama test
Exhibit 20: Global NIPT market for PrenaTest: Metric analysis 2016-2020
Exhibit 21: Global NIPT market for PrenaTest 2015-2020 ($ millions)
Exhibit 22: Global NIPT market segmentation by geography 2015
Exhibit 23: Global NIPT market segmentation by geography 2020
Exhibit 24: NIPT market in Americas 2015-2020 ($ millions)
Exhibit 25: NIPT market in EMEA 2015-2020 ($ millions)
Exhibit 26: NIPT market in APAC 2015-2020 ($ millions)
Exhibit 27: Non-invasive and invasive prenatal tests
Exhibit 28: Impact of drivers
Exhibit 29: Impact of drivers and challenges
Exhibit 30: Global NIPT market: Competitive landscape analysis 2015
Exhibit 31: BGI Genomics: Metrics analysis
Exhibit 32: Illumina: Metrics analysis
Exhibit 33: LifeCodexx: Metrics analysis
Exhibit 34: Natera: Metrics analysis
Exhibit 35: Sequenom: Metrics analysis
Exhibit 36: Other prominent vendors



【掲載企業】

BGI Genomics, Illumina, LifeCodexx, Natera, Sequenom, Ariosa Diagnostics, Berry Genomics, CombiMatrix, F. Hoffmann-La Roche, Genpharm Services, Laboratory Corporation of America Holdings, LifeLabs Genetics, Quest Diagnostics, Safembryo, Sengenics.


【レポートのキーワード】

新型出生前診断(NIPT)、MaterniT21 Plus検査、NIFTY検査、病院

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[新型出生前診断(NIPT)の世界市場2016-2020]販売に関する免責事項
★調査レポート[新型出生前診断(NIPT)の世界市場2016-2020]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆